Blog - INTERNET MÉDICA

■ 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: The Task Force for diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD)

F Cosentino, P J Grant, V Aboyans et al

European Heart Journal 2020, vol 41 (2): 255-323

https://academic.oup.com/eurheartj/article/41/2/255/5556890

■ Portuguese-Brazilian evidence-based guideline on the management of hyperglycemia in type 2 diabetes mellitus

Marcello Casaccia Bertoluci, João Eduardo Nunes Salles, José Silva-Nunes et al

Diabetol Metab Syndr. 2020; 12: 45

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245758/

■ 2019 update to: management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

J B Buse, D J Wexler, A Tsapas et al

Diabetologia 2020, vol 63: 221-228

https://link.springer.com/article/10.1007/s00125-019-05039-w

■ Consensus recommendations for management of patients with type 2 diabetes mellitus and cardiovascular diseases

A Bashier, A B Hussain, F Alawadi et al

Diabetology & Metabolic Syndrome 2019, vol 11, article number 80

https://dmsjournal.biomedcentral.com/articles/10.1186/s13098-019-0476-0

■ Consensus document: management of heart failure in type 2 diabetes mellitus

U Kaul, S Ray, D Prabhakar et al

Heart Failure Reviews may 2020

https://link.springer.com/article/10.1007/s10741-020-09955-7

■ Heart failure in type 2 diabetes mellitus: impact of glucose lowering agents, heart failure therapies and novel therapeutic strategies

Helena C. Kenny, E. Dale Abel

Circ Res. 2019 Jan 4; 124(1): 121–141

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6447311/

■ Diabetic cardiomyopathy: prevalence, determinants and potential treatments

Gaurav S. Gulsin, Lavanya Athithan, Gerry P. McCann

Ther Adv Endocrinol Metab. 2019; 10: 2042018819834869

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437329/

■ Diretriz brasielira baseada em evidências sobre prevenção de doenças cardiovasculares em pacientes com diabetes: posicionamento da Sociedade Brasileira de Diabetes (SBD), da Sociedade Brasileira de Cardiologia (SBC) e da Sociedade Brasileira de Endocrinologia e Metabologia (SBEM)

A A Faludi, M C O Izar, J F K Saraiva et al

Arq Bras Cardiol 2017, vol 109 (6), supl 1

https://www.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2017001600001&lng=en&nrm=iso&tlng=pt

■ Dr Paulo Fernando Leite

Cardiologia/Prevenção Cardiovascular

Consultório: Rua Padre Rolim 815/sala 601 – Belo Horizonte/MG/Brasil

Tel: 33245518

CRMMG: 7026

Email: pfleite1873@gmail.com

Blog Internet Médica – www.internetmedica.com.br

Data: fevereiro 2021